COC use, ACE/AGT gene polymorphisms, and risk of stroke.
Li
Ying
Y
NPFPC Contraceptives Adverse Reaction Monitoring Center, Jiangsu Research Centre for Reproductive Health in Humans, Feng Huang Xi Jie, Nanjing, China. liying2008@jsmail.com.cn
Chen
Feng
F
Zhou
Lifeng
L
Coulter
David
D
Chen
Cheng
C
Sun
Zhiming
Z
Chen
Jianfeng
J
Pan
Hongxin
H
Wu
Yulin
Y
Zhou
Jian
J
Ba
Lei
L
Zhao
Jinna
J
Shen
Hongbing
H
D000328:Adult; D000368:Aged; D000483:Alleles; D000808:Angiotensinogen / Q000235:genetics*; D001794:Blood Pressure; D016022:Case-Control Studies; D002681:China; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic; D012306:Risk; D012307:Risk Factors; D020521:Stroke / Q000235:genetics*
C534931:AGT protein, human; D003277:Contraceptives, Oral, Combined; D000808:Angiotensinogen; C488034:ACE protein, human; D007703:Peptidyl-Dipeptidase A